Autologous Immunotherapy in Malaysia | Autologous Cell Therapy - Carerm
We are developing a 3D co-culture platform from the biopsy tissue of the
cancer patient. We will screen various chemo regimes to provide the
short-list of the most efficacious chemo regimes in two weeks. We will
screen stand-alone drugs as well as various combinations of all chemo
drugs identified as potentially useful by the oncologist treating the
particular patient. This information would be extremely useful for the
physician (especially in the context of the second-line therapy) as it
helps reduce uncertainty in prescribing drug regimen that is most likely
to be effective for that particular cancer patient. The current
trial-and-error approach to identify the most effective cancer may lead
to significant loss of time (4 to 5 months) during which the patient may
continue to deteriorate.
Follow Us :